The Indian Pharmaceutical Alliance (IPA) has announced the appointment of Dr. Sharvil Patel, Managing Director of Zydus Lifesciences, as its new President. Dr. Patel will lead the industry body for the next two years, succeeding Samina Hamied, Executive Vice Chairperson of Cipla Ltd., who successfully
Zydus Therapeutics, a wholly owned subsidiary of Zydus Lifesciences Ltd., today announced encouraging topline results from its pivotal EPICS-III Phase 2(b)/3 clinical trial of Saroglitazar, a novel dual PPAR alpha/gamma agonist, for adult patients with Primary Biliary Cholangitis (PBC) who had an inadequate response or
Zydus Lifesciences Ltd. announced its unaudited consolidated financial results for the quarter and nine months ended December 31st, 2024.Key Financial HighlightsQ3 FY25 HighlightsRevenue from operations at Rs. 52,691 mn, up 17% over last year. Research & Development (R&D) investments for the quarter stood
In a significant move to address chronic kidney disease (CKD) complications, Zydus Lifesciences has announced a collaborative research agreement with the Lucknow-based CSIR-Central Drug Research Institute (CDRI) to develop an innovative oral medication targeting chronic kidney disease-induced osteoporosis.The partnership will focus on discovering small molecule
Zydus Lifesciences Limited (including its subsidiaries/ affiliates, hereafter referred to as “Zydus”) has received final approval from the United States Food and Drug Administration (USFDA) to market Scopolamine Transdermal System 1 mg/3 days. (USRLD: Transderm Scop Transdermal System ® 1 mg/3 days). This is the
Zydus Lifesciences Limited (including its subsidiaries/ affiliates, hereafter referred to as “Zydus”) today announced that the Mexican regulatory authority COFEPRIS (Federal Commission for the Protection Against Sanitary Risk), has granted marketing approval for MamitraTM, a Trastuzumab biosimilar. The drug will be marketed in different strengths
Need to harmonize traditional and modern medicine to combat alarming health problems: Sarbananda SonowalInvestment in Digital Technology to Extend India's Services Through Telemedicine: Dr Tedros Adhanom Ghebreyesus, Director General, WHODr Mansukh Mandaviya, Minister of Health and Family Welfare, Govt of India today said that India
Four Posters accepted at The Liver Meeting® 2022 Two Posters are awarded the “AASLD Presidential Poster Of Distinction”Ahmedabad, India November 03, 2022 Zydus Lifesciences Ltd. (formerly known as Cadila Healthcare Ltd.), a discovery-driven, global lifesciences company today announced that four abstracts on Saroglitazar Mg will be
